CD8A and neoplasm: These findings suggest that PF may enhance the anti-tumor efficacy of Sor by promoting the infiltration and anti-tumor immune activity of CD8+ T cells in tumor tissues through enhancing Th cells rather than Treg cells, consistent with previous studies on PF [47].